Company Search:
Advanced Search
Sponsored Links
CellSeed Incorporation Company Snapshot
CellSeed Incorporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares CellSeed Incorporation with three other companies in this sector in Japan: Oncolys Biopharma Inc (2015 sales of 121.30 million Japanese Yen [US$1.17 million] of which 100% was Test drug business), MediBIC Group (104.45 million Japanese Yen [US$1.01 million] of which 68% was inheritance business), and Raqualia Pharma Incorporated (145.50 million Japanese Yen [US$1.41 million] of which 100% was Pharmaceutical).

Sales Analysis. CellSeed Incorporation reported sales of ¥193.12 million (US$1.87 million) for the year ending December of 2015. This represents an increase of 123.7% versus 2014, when the company's sales were ¥86.33 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
CellSeed Incorporation
  Stock Performance Chart for CellSeed Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 593.00
(Figures in Japanese Yen)
1 Week -1.0%   13 Weeks 6.1%  
4 Weeks 7.0%   52 Weeks -1.3%  
CellSeed Incorporation Key Data:
  Ticker: 7776 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 193,118,000
(Year Ending Jan 2016).
Employees: 28
  Currency: Japanese Yen Market Cap: 5,464,075,156
  Fiscal Yr Ends: December Shares Outstanding: 9,214,292
  Share Type: Common Closely Held Shares: 1,408,218
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.